PT3980003T - Éster isopropílico do ácido [((1r,2s,5r)-2-isopropil-5-metil-ciclohexanocarbonil)-amino]-acético para tratamento de tosse crónica - Google Patents

Éster isopropílico do ácido [((1r,2s,5r)-2-isopropil-5-metil-ciclohexanocarbonil)-amino]-acético para tratamento de tosse crónica

Info

Publication number
PT3980003T
PT3980003T PT207325564T PT20732556T PT3980003T PT 3980003 T PT3980003 T PT 3980003T PT 207325564 T PT207325564 T PT 207325564T PT 20732556 T PT20732556 T PT 20732556T PT 3980003 T PT3980003 T PT 3980003T
Authority
PT
Portugal
Prior art keywords
isopropyl
cyclohexanecarbonyl
amino
methyl
treatment
Prior art date
Application number
PT207325564T
Other languages
English (en)
Original Assignee
Axalbion Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axalbion Sa filed Critical Axalbion Sa
Publication of PT3980003T publication Critical patent/PT3980003T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
PT207325564T 2019-06-10 2020-06-10 Éster isopropílico do ácido [((1r,2s,5r)-2-isopropil-5-metil-ciclohexanocarbonil)-amino]-acético para tratamento de tosse crónica PT3980003T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1908219.7A GB201908219D0 (en) 2019-06-10 2019-06-10 Therapeutic use of a compound

Publications (1)

Publication Number Publication Date
PT3980003T true PT3980003T (pt) 2024-03-05

Family

ID=67386245

Family Applications (1)

Application Number Title Priority Date Filing Date
PT207325564T PT3980003T (pt) 2019-06-10 2020-06-10 Éster isopropílico do ácido [((1r,2s,5r)-2-isopropil-5-metil-ciclohexanocarbonil)-amino]-acético para tratamento de tosse crónica

Country Status (26)

Country Link
US (1) US20220265594A1 (pt)
EP (2) EP3980003B1 (pt)
JP (1) JP7181426B2 (pt)
KR (1) KR20220019715A (pt)
CN (1) CN114007601A (pt)
AU (1) AU2020293622A1 (pt)
BR (1) BR112021024927A2 (pt)
CA (1) CA3143094C (pt)
CL (1) CL2021003301A1 (pt)
DK (1) DK3980003T3 (pt)
EA (1) EA202193006A1 (pt)
FI (1) FI3980003T3 (pt)
GB (1) GB201908219D0 (pt)
HR (1) HRP20240312T1 (pt)
IL (1) IL288874A (pt)
JO (1) JOP20210315A1 (pt)
LT (1) LT3980003T (pt)
MA (1) MA56105B1 (pt)
MD (1) MD3980003T2 (pt)
MX (1) MX2021014761A (pt)
PL (1) PL3980003T3 (pt)
PT (1) PT3980003T (pt)
RS (1) RS65224B1 (pt)
SI (1) SI3980003T1 (pt)
WO (1) WO2020249607A1 (pt)
ZA (1) ZA202109580B (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2819466C (en) * 2010-12-06 2019-11-26 Edward Tak Wei [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
US8426463B2 (en) 2011-04-04 2013-04-23 Edward T. Wei [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
EP3060219A1 (en) * 2013-10-22 2016-08-31 Edward Tak Wei 1-di(sec-butyl)-phosphinoyl-pentane (dapa-2-5) as a topical agent for the treatment of discomfort from non-keratinized stratified epithelial (nkse) tissue

Also Published As

Publication number Publication date
BR112021024927A2 (pt) 2022-01-18
FI3980003T3 (fi) 2024-03-01
LT3980003T (lt) 2024-03-12
MA56105A (fr) 2022-04-13
MX2021014761A (es) 2022-02-21
RS65224B1 (sr) 2024-03-29
CA3143094A1 (en) 2020-12-17
EP3980003A1 (en) 2022-04-13
AU2020293622A1 (en) 2022-02-03
EP4342533A3 (en) 2024-05-29
DK3980003T3 (da) 2024-02-19
JP2022534321A (ja) 2022-07-28
MD3980003T2 (ro) 2024-05-31
KR20220019715A (ko) 2022-02-17
MA56105B1 (fr) 2024-03-29
CA3143094C (en) 2023-11-07
WO2020249607A1 (en) 2020-12-17
IL288874A (en) 2022-02-01
PL3980003T3 (pl) 2024-05-20
US20220265594A1 (en) 2022-08-25
JP7181426B2 (ja) 2022-11-30
HRP20240312T1 (hr) 2024-05-10
CL2021003301A1 (es) 2022-08-19
EP3980003B1 (en) 2023-12-13
GB201908219D0 (en) 2019-07-24
ZA202109580B (en) 2023-04-26
CN114007601A (zh) 2022-02-01
EA202193006A1 (ru) 2022-03-17
SI3980003T1 (sl) 2024-05-31
EP4342533A2 (en) 2024-03-27
JOP20210315A1 (ar) 2023-01-30

Similar Documents

Publication Publication Date Title
SG11202003828WA (en) Process for the purification of a sialic acid from a fermentation broth
PH12017502228A1 (en) Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
WO2012048294A3 (en) Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
DOP2014000048A (es) Composiciones farmacéuticas que comprenden un polisacárido y un inhibidor hdac
HRP20180641T1 (hr) Pirolidinski gpr40 modulatori za liječenje bolesti kao što je dijabetes
WO2015179635A3 (en) Ras inhibitory peptides and uses thereof
MX2018000264A (es) Formulaciones topicas de diacereina de rheina y sus usos.
WO2016063299A3 (en) A novel purification process for isolation and commercial production of recombinant tnk-tpa (tenecteplase)
EP4041750A4 (en) DOSAGE FOR HDAC TREATMENT WITH REDUCED SIDE EFFECTS
IL248670B (en) Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes
IL288874A (en) [((5r,2s,1r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-isopropyl acetic acid ester for the treatment of chronic cough
EP3841257A4 (en) BEAM TO POST ASSEMBLY
WO2010062656A3 (en) Deuterated 2-propylpentanoic acid compounds
ZA201304896B (en) [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
RS62089B1 (sr) Aminska so (1r,3s)-3-(5-cijano-4-fenil-1,3-triazol-2-ylkarbamoil) ciklopentan karboksilne kiseline
EP3560912A4 (en) PROCESS FOR PREPARING AN AROMATIC NITRIL COMPOUND AND METHOD FOR PRODUCING A CARBOXYLIC ACID ESTER
HUP1700109A1 (en) Process for the separation of optical isomers of the racemic mixture of 3-alkyl-piperidine-3-carboxylic acid ethyl ester
PH12020550124A1 (en) Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor
GB201710739D0 (en) 3-trichloroacetyl-2, 2-dimethylcyclopropanecarboxylic acid ethyl ester drug synthesis method
UA91650U (uk) Фармацевтична композиція похідних гамма-аміномасляної кислоти для твердих капсул